Y. Zhang

LBA79 GEMSTONE-303: Prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase III study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naïve advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

Xiao Zhang, J. Wang, Guoping Wang et al. · Annals of Oncology · 2023 · 31 citations · Full text

Medicine, Oncology, Chemotherapy +12

Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer

M. Cheng, Renying Lin, Na Bai et al. · Clinical Radiology · 2023 · 24 citations · Full text

Medicine, Immunology, Oncology +16

987P A phase Ib study of the PD-1 antagonist CS1003 plus lenvatinib (LEN) in Chinese patients (pts) with the first-line (1L) unresectable hepatocellular carcinoma (uHCC)

Lin Shen, Y. Zhang, Ye Guo et al. · Annals of Oncology · 2020 · 12 citations

Medicine, Oncology, Pharmacology +15